Intel, Gilead Sciences rise; Amazon, DaVita fall
October 28, 2022 GMTNEW YORK (AP) — Stocks that traded heavily or had substantial price changes Friday:
Exxon Mobil Corp., up $3.15 to $110.70.
The oil and natural gas company beat Wall Street's third-quarter profit and revenue forecasts.
Bristol-Myers, Gilead rise, SVB Financial, BioMarin fall
September 12, 2022 GMTNEW YORK (AP) — Stocks that traded heavily or had substantial price changes Monday:
Bristol-Myers Squibb Co., up $2.20 to $72.36.
The pharmaceutical company received U.S. approval for a psoriasis treatment.
Unity Software, Turquoise Hill fall; Gilead, Moderna rise
August 15, 2022 GMTNEW YORK (AP) — Stocks that traded heavily or had substantial price changes Monday:
Exxon Mobil Corp.. down $1.68 to $92.32.
Energy stocks slipped along with falling crude oil prices.
PayPal, CVS rise; Match Group, Mercury Systems fall
August 3, 2022 GMTNEW YORK (AP) — Stocks that traded heavily or had substantial price changes Wednesday:
Advanced Micro Devices Inc., down $1.20 to $98.09.
The chipmaker gave investors a disappointing revenue forecast for the current quarter.
Gilead: Q2 Earnings Snapshot
August 2, 2022 GMTFOSTER CITY, Calif. (AP) _ Gilead Sciences Inc. (GILD) on Tuesday reported second-quarter earnings of $1.14 billion.
The Foster City, California-based company said it had profit of 91 cents per share.
Gilead: Q1 Earnings Snapshot
April 28, 2022 GMTFOSTER CITY, Calif. (AP) _ Gilead Sciences Inc. (GILD) on Thursday reported first-quarter profit of $19 million.
The Foster City, California-based company said it had profit of 2 cents per share.
Alphabet, Brinker International rise; PayPal, Gilead fall
February 2, 2022 GMTStocks that traded heavily or had substantial price changes Wednesday:
Alphabet Inc., up $207.12 to $2,960.
Google's parent company beat Wall Street's fourth-quarter financial forecasts and announced a 20-for-1 stock split.
AIDS fight enters new phase with prevention pill
May 11, 2012 GMTCHICAGO (AP) — Condoms and other safe-sex practices have accomplished only so much. Now the 30-year battle against AIDS is on the verge of a radical new phase, with the government expected to endorse a once-a-day pill to prevent infection with the virus.